Company

Recourse Biologics

Biotechnology Research 5 employees EXOZ

Employees: 5
Contacts: 1
Emails: 1
Phones: 1

www.recoursebio.com LinkedIn

Recourse Biologics Overview

Website: www.recoursebio.com
Industry: Biotechnology Research
Employees: 5
Stock Symbol: EXOZ
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in cellular immunology | Highly collaborative

About Recourse Biologics

Recourse Biologics is committed to advancing new and improved therapies for oncology. Our lead molecule is RB101. RB101 is a first-in-class immunotherapeutic that increases professional killer cell persistence, memory formation, and cytotoxicity without systemic toxicity or exhaustion. RB101 is 12 months from IND. In addition to RB101, Recourse Biologics has created an improved method of targeting and redirecting cytotoxic lymphocytes within the tumor microenvironment using our bispecific antibody platform.

Recourse Biologics Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage
Phone contacts: 1; 33.3% coverage

Recourse Biologics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Alexander Krupnick	Professor of Surgery, Microbiology and Immunology at University of Maryland School of Medicine	Baltimore, Maryland, United States	View
John Westwick		Houston, Texas, United States	Email Phone
Nianbin Song	Innovative Immunologist with Ph.d. and Extensive Expertise in Cellular Immunology - Highly Collaborative, Detail-oriented, Experienced		View